Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

OSTEOARTHRITIS

Cholesterol and cartilage do not mix well

The molecular mechanisms responsible for initiation and progression of osteoarthritis (OA) are incompletely understood. New data implicate cholesterol, its metabolites and the receptor RORα as catabolic drivers of OA-like disease in mice, but do these data identify new targets for treating patients with OA?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Zai, G. Alteration of metabolic pathways in osteoarthritis. Metabolites 9, 11 (2019).

    Article  Google Scholar 

  2. Choi, W. S. et al. The CH25H–CYP7B1–RORα axis of cholesterol metabolism regulates osteoarthritis. Nature 566, 254–258 (2019).

    Article  CAS  Google Scholar 

  3. Sun, M. M., Beier, F. & Ratneswaran, A. Nuclear receptors as emerging drug targets in osteoarthritis. Curr. Opin. Pharmacol. 40, 81–86 (2018).

    Article  CAS  Google Scholar 

  4. Ali, S. A. et al. Regulation of cholesterol homeostasis by Hedgehog signaling in osteoarthritic cartilage. Arthritis Rheumatol. 68, 127–137 (2016).

    Article  CAS  Google Scholar 

  5. Farnaghi, S. et al. Cholesterol metabolism in pathogenesis of osteoarthritis disease. Int. J. Rheum. Dis. 20, 127–130 (2017).

    Article  Google Scholar 

  6. Woods, A. et al. Control of chondrocyte gene expression by actin dynamics: a novel role of cholesterol/ROR-alpha signalling in endochondral bone growth. J. Cell. Mol. Med. 13, 3497–3516 (2009).

    Article  Google Scholar 

  7. Yamashita, A. et al. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature 513, 507–511 (2014).

    Article  CAS  Google Scholar 

  8. Tang, J. et al. Fibroblast growth factor receptor 3 inhibits osteoarthritis progression in the knee joints of adult mice. Arthritis Rheumatol. 68, 2432–2443 (2016).

    Article  CAS  Google Scholar 

  9. Ikonen, E. Cellular cholesterol trafficking and compartmentalization. Nat. Rev. Mol. Cell Biol. 9, 125–138 (2008).

    Article  CAS  Google Scholar 

  10. Sidman, R. L., Lane, P. W. & Dickie, M. M. Staggerer, a new mutation in the mouse affecting the cerebellum. Science 137, 610–612 (1962).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The author thanks the Canadian Institutes of Health Research (CIHR), the Arthritis Society and the Canada Research Chair Program for funding his research, and all the members of his lab for ongoing discussions.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frank Beier.

Ethics declarations

Competing interests

The author declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Beier, F. Cholesterol and cartilage do not mix well. Nat Rev Rheumatol 15, 253–254 (2019). https://doi.org/10.1038/s41584-019-0204-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41584-019-0204-z

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing